Eli Lilly hits $1 trillion market value, a first for a health-care company
The pharmaceutical giant Eli Lilly’s stock has been riding the skyrocketing demand for its weight loss injection Zepbound and diabetes treatment Mounjaro.
Source link
Get latast news super fast
The pharmaceutical giant Eli Lilly’s stock has been riding the skyrocketing demand for its weight loss injection Zepbound and diabetes treatment Mounjaro.
Source link